Algernon Pharmaceuticals Inc. (AGN.CN)
CAD 0.09
(6.25%)
CAD 0.09
(6.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 50.39 Thousand | 34.93 Thousand | - | - | 26.99 Thousand | 40.95 Thousand |
| Gross Profit | -50.39 Thousand | -34.93 Thousand | - | - | -26.99 Thousand | -40.95 Thousand |
| Operating Expenses | 5.19 Million | 6.05 Million | 8.05 Million | 8.67 Million | 1.91 Million | 948.55 Thousand |
| Selling, General and Administrative Expenses | 3.93 Million | 3.72 Million | 3.25 Million | 5.98 Million | 1.3 Million | 854.73 Thousand |
| Research and Development Expenses | 1.04 Million | 2.32 Million | 4.79 Million | 2.69 Million | 605.73 Thousand | 93.81 Thousand |
| Other Expenses | - | - | 305.11 Thousand | 16.04 Thousand | - | - |
| Cost and Expenses | 5.24 Million | 6.05 Million | 8.05 Million | 8.67 Million | 1.91 Million | 948.55 Thousand |
| Operating Income | -5.01 Million | -6.05 Million | -8.05 Million | -8.76 Million | -1.92 Million | -948.55 Thousand |
| Interest Expense | - | 2078.00 | - | - | - | 10.96 Thousand |
| Income Tax Expense | 1.53 Million | -4156.00 | -11.92 Thousand | -122.84 Thousand | -18.34 Thousand | -21.92 Thousand |
| Earnings before Tax | -6.78 Million | -6.05 Million | -7.73 Million | -8.53 Million | -1.89 Million | -937.59 Thousand |
| Net Income | -6.78 Million | -6.05 Million | -7.72 Million | -8.41 Million | -1.87 Million | -937.59 Thousand |
| Earnings Per Share Basic | -0.45 | -0.73 | -1.04 | -2.00 | -0.88 | -0.70 |
| Earnings Per Share Diluted | -0.45 | -0.73 | -1.04 | -2.00 | -0.88 | -0.70 |
| Weighted Average Shares Outstanding | 15.14 Million | 8.29 Million | 7.43 Million | 4.2 Million | 2.13 Million | 1.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.14 Million | 8.29 Million | 7.43 Million | 4.2 Million | 2.13 Million | 1.34 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -4.98 Million | -6.01 Million | - | -8.53 Million | -1.86 Million | -896.64 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 6085.00 | 7642.00 | 7428.00 | 13.33 Thousand | 50.39 Thousand | 12.83 Thousand |
| Gross Profit | -6085.00 | -7642.00 | -7428.00 | -13.33 Thousand | -50.39 Thousand | -12.83 Thousand |
| Operating Expenses | 459.57 Thousand | 1004.21 | 521.97 Thousand | 985.84 Thousand | 5.24 Million | 1.12 Million |
| Selling, General and Administrative Expenses | 355.56 Thousand | 641.34 | 335.52 Thousand | 797.48 Thousand | - | 667.45 Thousand |
| Research and Development Expenses | 104 Thousand | 339.01 | 167.57 Thousand | 188.35 Thousand | - | 460.57 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 465.65 Thousand | 1004.21 | 521.97 Thousand | 985.84 Thousand | 5.24 Million | 1.12 Million |
| Operating Income | -465.66 Thousand | -980.36 | -521.97 Thousand | -985.84 Thousand | -3.7 Million | -1.12 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -5.00 | - | -35.84 Thousand | -30.47 Thousand | 1.53 Million | 52.41 Thousand |
| Earnings before Tax | 1.44 Million | -1003.90 | -521.55 Thousand | -2.52 Million | -6.78 Million | -1.12 Million |
| Net Income | 1.44 Million | -1003.90 | -521.55 Thousand | -2.52 Million | -6.78 Million | -1.12 Million |
| Earnings Per Share Basic | 0.07 | -0.00 | -0.03 | -0.16 | - | -0.10 |
| Earnings Per Share Diluted | 0.07 | -0.00 | -0.03 | -0.16 | - | -0.10 |
| Weighted Average Shares Outstanding | 21.77 Million | 19.21 Million | 15.77 Million | 15.77 Million | 15.14 Million | 11.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.77 Million | 20.07 Million | 15.77 Million | 15.77 Million | 15.14 Million | 11.09 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -459.58 Thousand | -972.71 | -514.54 Thousand | -972.5 Thousand | - | -1.11 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ALCLA
1ET
UGARSUGAR
ATCH
VTMXF
DRCSYSTEMS